
MiniMed Smart MDI system users with higher alert responses improve glucose control significantly in type 1 diabetes trial.
A six-month randomized trial involving 143 type 1 diabetes patients showed that users of the MiniMed Smart MDI system who responded more frequently to missed-dose and high-glucose alerts achieved 8.1 percentage points more Time in Range (TIR) and 0.6...





